Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2000, p. 2996-3003, Vol. 20, No. 9
Department of Biochemistry and
Biophysics,1 Curriculum in Genetics and
Molecular Biology,2 and Lineberger
Comprehensive Cancer Center,3 University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina
Received 6 December 1999/Returned for modification 10 January
2000/Accepted 2 February 2000
Genetic experiments have determined that Ku, XRCC4, and ligase IV
are required for repair of double-strand breaks by the end-joining pathway. The last two factors form a tight complex in cells. However, ligase IV is only one of three known mammalian ligases and is intrinsically the least active in intermolecular ligation; thus, the
biochemical basis for requiring this ligase has been unclear. We
demonstrate here a direct physical interaction between the XRCC4-ligase
IV complex and Ku. This interaction is stimulated once Ku binds to DNA
ends. Since XRCC4-ligase IV alone has very low DNA binding activity, Ku
is required for effective recruitment of this ligase to DNA ends. We
further show that this recruitment is critical for efficient
end-joining activity in vitro. Preformation of a complex containing Ku
and XRCC4-ligase IV increases the initial ligation rate 20-fold,
indicating that recruitment of the ligase is an important limiting step
in intermolecular ligation. Recruitment by Ku also allows XRCC4-ligase
IV to use Ku's high affinity for DNA ends to rapidly locate and ligate
ends in an excess of unbroken DNA, a necessity for end joining in
cells. These properties are conferred only on ligase IV, because Ku
does not similarly interact with the other mammalian ligases. We have
therefore defined cell-free conditions that reflect the genetic
requirement for ligase IV in cellular end joining and consequently can
explain in molecular terms why this factor is required.
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Ku Recruits the XRCC4-Ligase IV Complex to
DNA Ends
*
Corresponding author. Mailing address: Rm. 32-044, Lineberger Comprehensive Cancer Center, Campus Box 7295, Mason Farm
Rd., University of North Carolina at Chapel Hill, Chapel Hill, NC
27599-7295. Phone: (919) 966-9839. Fax: (919) 966-3015. E-mail:
Dale_Ramsden{at}med.unc.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|